 CAMBRIDGE, Mass. and GOSSELIES, Belgium, Feb. 17, 2021 GLOBE NEWSWIRE -- iTeos Therapeutics, Inc. Nasdaq: ITOS, a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients, today announced that Michel Detheux, PhD, President and Chief Executive Officer, will host a fireside chat at the virtual 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24, 2021 at 3:00 p.m. ET. 